beta

CMRX

Chimerix, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.

Market Cap: 207 Million

Primary Exchange: NASDAQ

Website: http://www.chimerix.com

Shares Outstanding: 61.9 Million

Float: 45.8 Million

Dividend: (%)

Beta: 0.913988858101483

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1255 trading days

From: 2015-08-05 To: 2020-05-22

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud